- Home
- AGO vs PGEN Comparison
AGO vs PGEN Comparison
Compare AGO & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AGO | PGEN |
|---|---|---|
| Founded | 2003 | 1998 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.8B |
| IPO Year | 2003 | 2013 |
Fundamental Metrics
Financial Performance| Metric | AGO | PGEN |
|---|---|---|
| Price | $73.05 | $4.76 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $91.00 | $14.00 |
| AVG Volume (30 Days) | 319.2K | ★ 7.3M |
| Earning Date | 11-05-2026 | 11-04-2026 |
| Dividend Yield | ★ 2.06% | N/A |
| EPS Growth | ★ 49.34 | N/A |
| EPS | ★ 4.55 | 0.12 |
| Revenue | ★ $1,110,000,000.00 | $230,981,000.00 |
| Revenue This Year | $6.21 | $2,335.22 |
| Revenue Next Year | N/A | $85.34 |
| P/E Ratio | ★ $16.17 | $38.92 |
| Revenue Growth | ★ 27.29 | N/A |
| 52 Week Low | $67.24 | $3.04 |
| 52 Week High | $92.40 | $8.98 |
Technical Indicators
Market Signals| Indicator | AGO | PGEN |
|---|---|---|
| Relative Strength Index (RSI) | 58.10 | 36.60 |
| Support Level | $67.80 | $3.50 |
| Resistance Level | $76.96 | $5.75 |
| Average True Range (ATR) | 1.55 | 0.47 |
| MACD | 0.42 | -0.13 |
| Stochastic Oscillator | 67.57 | 26.57 |
Price Performance
Historical ComparisonAbout AGO Assured Guaranty Ltd.
Assured Guaranty Ltd. provides credit protection products to the United States and international public finance and structured finance markets and manages assets across collateralized loan obligations as well as opportunity funds and liquid funds that build on its corporate credit, asset-based finance, municipal, and healthcare experience. The company operates in two segments: the Insurance segment and the Asset Management segment. The majority of the revenue earned by the company is from the Insurance segment.
About PGEN Precigen Inc.
Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.